A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multi-center, open-label, all-comers OTC actual use study in pharmacy sites where the principal investigator will be a pharmacist.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eisai Inc.
• Treatments: Rabeprazole

Criteria

INCLUSION CRITERIA

To be eligible for participation, consumers must:

• Male or female, 18 years of age or older

• Select and purchase the study medication for their own use

• Be able to take part in periodic telephone interviews regarding their use of and experience with the medication

• Give written informed consent for participation

EXCLUSION CRITERIA Consumers will be excluded from participation if they meet any of the following criteria:

• Allergic to rabeprazole

• Currently have trouble or pain swallowing food

• Currently have vomiting with blood

• Currently have bloody or black stool

• Currently pregnant or breast-feeding

• Participated in a study regarding a heartburn medication during the last 12 months